Search results: Sage Journals

Open accessResearch articleFirst published June, 2023

Effect of secretory DKK3 on circulating CD56 bright natural killer cells in patients with liver cancer

Da-Hua Liu, Gui-Min Wen, Chang-Liang Song [...]

The International Journal of Biological Markers

Restricted accessResearch articleFirst published December, 2013

CD3 − CD16 − CD56 bright Immunoregulatory NK Cells are Increased in the Tumor Microenvironment and Inversely Correlate with Advanced Stages in Patients with Papillary Thyroid Cancer

Foteini Gogali, George Paterakis, George Z. Rassidakis [...]

Thyroid®

Restricted accessResearch articleFirst published December, 2011

Intermediate-affinity interleukin-2 receptor expression predicts CD56 bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis

James P Sheridan, Ying Zhang, Katherine Riester [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published October, 2017

Natural killer cell subpopulations are associated with MRI activity in a relapsing-remitting multiple sclerosis patient cohort from Australia

P Caruana, K Lemmert, K Ribbons [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published April, 2020

Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations

Netanya S. Utay, Karen J. Vigil, Anoma Somasunderam [...]

AIDS Research and Human Retroviruses

Restricted accessResearch articleFirst published November, 2012

Ex Vivo Generated Natural Killer Cells Acquire Typical Natural Killer Receptors and Display a Cytotoxic Gene Expression Profile Similar to Peripheral Blood Natural Killer Cells

Dorit Lehmann, Jan Spanholtz, Markus Osl [...]

Stem Cells and Development

Restricted accessResearch articleFirst published April, 2003

Immunologic Effects of Intermediate-Dose IL-2 i.v. After Autologous Hematopoietic Cell Transplantation in Pediatric Solid Tumors

Krzysztof Kalwak, Marek Ussowicz, Ewa Gorczyńska [...]

Journal of Interferon & Cytokine Research

Open accessResearch articleFirst published December, 2017

Influence of a Moderate-Intensity Exercise Program on Early NK Cell Immune Recovery in Pediatric Patients After Reduced-Intensity Hematopoietic Stem Cell Transplantation

Carolina Chamorro-Viña, Jaime Valentín, Lucía Fernández [...]

Integrative Cancer Therapies

Restricted accessResearch articleFirst published February, 2012

Effects on Innate Immunity of a Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection

José Peña, Mario Frías, Laura Castro-Orgaz [...]

Viral Immunology

Free accessReview articleFirst published January, 2014

The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis

Ron Milo

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published June, 2023

Effect of secretory DKK3 on circulating CD56 bright natural killer cells in patients with liver cancer

Da-Hua Liu, Gui-Min Wen, Chang-Liang Song [...]

The International Journal of Biological Markers

Restricted accessResearch articleFirst published December, 2013

CD3 − CD16 − CD56 bright Immunoregulatory NK Cells are Increased in the Tumor Microenvironment and Inversely Correlate with Advanced Stages in Patients with Papillary Thyroid Cancer

Foteini Gogali, George Paterakis, George Z. Rassidakis [...]

Thyroid®

Restricted accessResearch articleFirst published December, 2011

Intermediate-affinity interleukin-2 receptor expression predicts CD56 bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis

James P Sheridan, Ying Zhang, Katherine Riester [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published October, 2017

Natural killer cell subpopulations are associated with MRI activity in a relapsing-remitting multiple sclerosis patient cohort from Australia

P Caruana, K Lemmert, K Ribbons [...]

Multiple Sclerosis Journal

Restricted accessResearch articleFirst published April, 2020

Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations

Netanya S. Utay, Karen J. Vigil, Anoma Somasunderam [...]

AIDS Research and Human Retroviruses

Restricted accessResearch articleFirst published November, 2012

Ex Vivo Generated Natural Killer Cells Acquire Typical Natural Killer Receptors and Display a Cytotoxic Gene Expression Profile Similar to Peripheral Blood Natural Killer Cells

Dorit Lehmann, Jan Spanholtz, Markus Osl [...]

Stem Cells and Development

Restricted accessResearch articleFirst published April, 2003

Immunologic Effects of Intermediate-Dose IL-2 i.v. After Autologous Hematopoietic Cell Transplantation in Pediatric Solid Tumors

Krzysztof Kalwak, Marek Ussowicz, Ewa Gorczyńska [...]

Journal of Interferon & Cytokine Research

Open accessResearch articleFirst published December, 2017

Influence of a Moderate-Intensity Exercise Program on Early NK Cell Immune Recovery in Pediatric Patients After Reduced-Intensity Hematopoietic Stem Cell Transplantation

Carolina Chamorro-Viña, Jaime Valentín, Lucía Fernández [...]

Integrative Cancer Therapies

Restricted accessResearch articleFirst published February, 2012

Effects on Innate Immunity of a Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection

José Peña, Mario Frías, Laura Castro-Orgaz [...]

Viral Immunology

Free accessReview articleFirst published January, 2014

The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis

Ron Milo

Therapeutic Advances in Neurological Disorders